Mylan’s stock plunges on outlook

Sharing is Caring

Mylan’s shares dropped after it said that delays in launching key new drugs and lower prices for generics in the United States will hurt its profitability this and next year. Fred Katayama reports.

Mylan’s stock plunges on outlook

Tags : Mylan nv, Mylan nvepipen allergy treatment, Myl, Drugmakers, prices, Fred katayama, Hurt profitability, Generic, Launching key new drug, Epipen allergy treatment

Related Videos :

You may also like...

Leave a Reply